Publicaciones en colaboración con investigadores/as de John Radcliffe Hospital (3)

2023

  1. Ravulizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

    Annals of Neurology, Vol. 93, Núm. 6, pp. 1053-1068

2022

  1. Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension

    Multiple Sclerosis Journal, Vol. 28, Núm. 3, pp. 480-486

2021

  1. Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD

    Annals of Neurology, Vol. 89, Núm. 6, pp. 1088-1098